Video & Transcript : 'pharmaceutical compounding' :
Page 27 of 172
HI
Transcript Highlights:
- Tona Sorell, Neil Pharmaceutical Care Management Association, in opposition.
- support ton center Association and support ton sorell<00:04:40.479><c> Neil</c><00:04:41.160><c> pharmaceutical
- </c><00:04:41.919><c> Care</c> sorell Neil pharmaceutical Care sorell Neil pharmaceutical Care Management
Summary:
The joint hearing began with SB 59 on prescription drugs, which drew extensive testimony from insurers, pharmacies, patient advocates, and health organizations. Supporters argued the bill would address PBM practices such as spread pricing, unclear reimbursement, and patient steering, and would help independent pharmacies and lower patient costs by passing rebates through to consumers. Opponents from health plans and PBM-related groups raised concerns, while Walgreens supported the measure and suggested amendments to establish a reimbursement floor. After questions, the committee accepted the Hawaii Pharmacist Association’s proposed amendments, added technical changes and a defective date of December 31, 2050, and voted to pass SB 59 with amendments.
The remainder of the hearing focused on a series of nominations and reappointments to health, aging, disability, mental health, juvenile justice, and advisory boards. Nominees and agency representatives generally described their backgrounds and interest in serving, with support testimony emphasizing experience, continuity, and the value of volunteer service. Several nominees highlighted issues such as mental health access, substance abuse treatment, elder services, language access, disability access, and rehabilitation services. The Department of Health, SHPDA, DHS, and other organizations largely testified in support of the nominees.
No votes were taken on the nominations during the transcript excerpt, and the chair repeatedly thanked the nominees for their service and testimony. The hearing also included brief procedural remarks about time limits, Zoom testimony, and a possible reconvening date in case of technical difficulties.
CA
California 2025-2026 Regular Session
Senate Business, Professions and Economic Development Committee Apr 6th, 2026
Transcript Highlights:
- Alison Ramey on behalf of the Pharmaceutical Care Management Association in support. Thank you.
- encourage biosimilar use to bring down the cost and inject more competition into a system that pharmaceutical
Summary:
The Senate Business, Professions and Economic Development Committee heard SB 1094 by Senator Weber Pearson, which would expand pharmacist and health plan authority to substitute biosimilars for reference biologic drugs in order to lower prescription drug costs. The author and supporters, including Blue Shield of California, Sharp HealthCare, and several business and health groups, argued that biologics are a major driver of rising health care spending and that biosimilars can provide substantial savings while maintaining safety and efficacy. The bill also included transparency provisions and committee amendments, including notice requirements and clarifications around substitution and exceptions.
Opposition came from the Biotechnology Innovation Organization, the California Rheumatology Alliance, and Biocom, who said the bill was not scientifically justified, could undermine FDA standards, and might lead to unwanted switching, side effects, or delays in care for patients with chronic conditions. They emphasized that pharmacists can already substitute interchangeable biosimilars and that non-interchangeable products can be changed with prescriber contact. Committee discussion focused on patient safety, the meaning of “do not substitute,” the 30-day notice provisions, and the distinction between biosimilars and interchangeable biosimilars.
After debate, the committee adopted a due pass as amended motion to the Senate Health Committee. The bill passed the committee on a 10-0 roll call vote and was sent onward.
HI
Hawaii 2026 Regular Session
ECD Public Hearing - Wed Mar 18, 2026 @ 8:30 AM HST
Economic Development & Technology
Keywords:
permit processing, permitting reform, county permits, development permits, building permits, land use, construction delays, housing development, infrastructure development, county workforce, differential pay, salary incentive, performance bonus, recruitment and retention, expedited hiring, vacancy rates, permit backlog, government modernization, county mayor, county council
Summary:
The committee heard testimony on several Senate bills, with most measures drawing broad support and a few generating significant opposition or policy questions. SB 2908 SD1 and SB 2671 SD1 were taken up first; both appeared to have majority support, with SB 2908 receiving seven in support, one in opposition, and one comment, and SB 2671 receiving five in support and two comments. SB 3085 SD2, related to film industry operations, drew 11 supporters and no opposition. Georgia Skinner explained that the bill would streamline the approval timeline for productions by reducing delays tied to Land Board review, and she said DLNR supported the effort. Committee members asked about the need for the change and the relationship between the film studio, DLNR, and the approval process.
The committee then discussed SB 2907 SD1, which would create an Office of Marine Affairs. Testimony was largely supportive, including from DLNR, HTDC, the Department of Agriculture and Biosecurity, ocean industry representatives, and others. The governor’s office supported the bill’s intent but objected to placing the office within the Office of the Governor, urging instead that it be housed at HTDC. HTDC said it was willing and excited to take on the work and described ongoing stakeholder engagement. Members asked about the rationale for the placement and the long-term structure of the office.
SB 2353 SD2, concerning the Aloha Stadium district and billboard/naming-rights issues, drew strong opposition overall, with four in support, 23 in opposition, and one comment. Andrew Pereira of the Stadium Authority argued the measure could generate revenue to help maintain and operate the stadium and said the district would remain self-contained; he also emphasized that the development would respect the character of the area. The committee then heard SB 2074 SD1, which had five in support and 26 in opposition; only one support testimony from the Carpenters was heard before the discussion moved on. Finally, SB 2360 SD1, an enterprise zones measure, received 14 supportive testimonies and two comments. Testimony focused on updating the program for modern business models, especially e-commerce and direct-to-consumer sales, while committee members questioned whether the program overlaps with higher tax burdens and whether businesses receiving subsidies should be monitored for job retention after graduation from the program.
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on State Administration and Regulatory Oversight Jun 21st, 2026 at 01:00 pm
Joint Committee on State Administration and Regulatory Oversight
Transcript Highlights:
- years, I've worked directly with individuals diagnosed with Tourette syndrome as part of multiple pharmaceutical
- show that we can't incarcerate our way into safety and that the family separation of incarceration compounds
Summary:
The committee on State Administration and Regulatory Oversight held a hybrid hearing covering public construction, business regulations, and honorary designations, with most of the discussion focused on two matters: a five-year moratorium on new jail and prison construction (S. 2114/H. 3422) and a bill designating June 7 as Tourette Syndrome Awareness Day (S. 2152/H. 3305). The chair emphasized that the hearing was public, testimony would be recorded, and speakers should generally keep remarks to three minutes. Senator Comerford introduced the prison moratorium bill, saying it would pause new construction while allowing renovations, and Senator Friedman introduced the Tourette awareness bill and a separate Tuskegee Airmen commemoration measure, asking for favorable action on both honorary designations.
A large portion of the hearing featured remote testimony from incarcerated people at MCI Framingham and MCI Shirley in support of the prison moratorium. Witnesses repeatedly argued that Massachusetts does not need a new women’s prison, that the incarcerated population is declining, and that funds would be better spent on mental health care, addiction treatment, vocational training, pre-release programming, housing, and repairs to existing facilities. Several speakers described poor conditions, limited programming, and the need to address trauma, domestic violence, and substance use as root causes of incarceration. One committee member responded to testimony by noting that incarceration numbers are going down, that the state is working on housing and workforce opportunities for people returning home, and that the committee wants to expand pathways to employment and reentry.
The Tourette Syndrome Awareness Day bill drew testimony from the bill’s young sponsor, Owen Rosenthal, his parents, medical professionals, and advocates. They described Tourette syndrome as a misunderstood neurodevelopmental condition, said awareness would reduce stigma and improve diagnosis and support, and cited the need for education in schools, workplaces, and the medical community. The Tourette Association of America supported the bill, noting underdiagnosis, co-occurring conditions, pain, and mental health risks associated with Tourette syndrome. Committee members praised the youth advocates and asked that written testimony be submitted electronically. The hearing ended without any recorded votes or final committee action in the transcript provided.
ID
Idaho 2026 Regular Session
Agenda Jan 14th, 2026
Transcript Highlights:
- Utilization pharmaceutical drugs is also a big cost driver there, but medical costs seem to be a big
- If you think about the CAGR, or the compound annual growth rate, of rates, of electricity rates, over
Summary:
The committee was convened to review Idaho’s economic outlook and general fund revenue projections, with members instructed to complete and submit individual “homework” revenue projections for fiscal years 2026, 2027, and 2028 by noon the next day. Chairmen explained the binder materials, the committee’s constitutional charge, and the plan to compile member projections into an average and median for deliberation and a recommendation to JFAC. They also noted the meeting was being broadcast publicly and thanked staff and presenters.
Keith Bybee of Legislative Services Office outlined the state’s general fund budget picture, emphasizing structural imbalance between revenues and expenditures, the impact of statutory spending growth, and the need to decide whether to address the gap through spending cuts, cash balances, or other policy changes. He highlighted major budget drivers such as Medicaid expansion, public defender costs, IT consolidation, public school funding changes, and water resources spending, and discussed available cash reserves, including the budget stabilization fund. Committee members asked about Medicaid’s net cost, the treatment of the $330 million school funding adjustment, the Millennium Fund, and whether rainy-day funds or interest earnings were being used in the governor’s budget.
Aaron Phipps of the Division of Financial Management presented the executive revenue forecast and explained changes in reporting for sales tax and the tax relief fund, including how certain transfers would now be treated as accrued general fund revenue. She described a sharp but likely temporary drop in corporate income tax collections tied to federal tax changes and taxpayer behavior, especially the One Big Beautiful Bill Act and the SALT workaround, and said the overall income tax forecast remained relatively steady. Robert Spindlove of Zions Bank described national conditions, including lower Fed rates, a re-steepening yield curve, higher tariffs, mixed inflation signals, slowing but not contracting labor markets, and continued consumer spending, and said 2026 looked like a rebuilding year. Sam Wilkenhauer of the Idaho Department of Labor reported that Idaho’s labor market remained strong, with low unemployment, steady job growth, balanced industry expansion, and wage growth moderating from the overheated post-pandemic period; he forecast continued but more sustainable growth over the next two years.
TX
MN
Minnesota 2025-2026 Regular Session
House Floor Session - part 2 May 12th, 2025
Minnesota House Floor Meeting
Transcript Highlights:
- And having pharmaceuticals pay attention to these prices that determine our lives.
- But if we compound this, members, with more mandates on their rules of how they give benefits to their
TX
Texas 89th Regular
Pensions, Investments & Financial Services Apr 14th, 2025
Pensions, Investments & Financial Services
Transcript Highlights:
- Let time work its magic and take full advantage of compounded interest.
- And like a lot of other things, whether you're talking about defense spending or pharmaceuticals or a
Bills:
HB245, HB700, HB2783, HB3526, HB3900, HB4061, HB4124, HB4166, HB4395, HB4534, HB4609, HB4641, HB4736, HB4738, HB4739, HB4945, HB5015, HJR175, HB245
Keywords:
military service, retirement, law enforcement, custodial officer, Employees Retirement System, commercial financing, brokers, registration, disclosures, finance, consumer protection, fees, deferred compensation, automatic participation, county employees, payroll deductions, retirement plans, fiscal transparency, local government, bond issuance
FL
Florida 2025 Regular Session
Judiciary Apr 1st, 2025
PA
Transcript Highlights:
- employment gains, high research and development investment, and a concentration of innovation in pharmaceuticals
- Speaker, the legislation we can consider today helps to further growth and innovation by allowing pharmaceutical
- This legislation was born out of a pharmaceutical factory tour organized by the Competitiveness Caucus
Summary:
The House convened with a quorum, recognized several guests in the gallery, and then took up a series of committee reports, referrals, and floor actions. Early business included concurrence in committee reports on bills and resolutions from Game and Fisheries, Professional Licensure, Health, and Children and Youth, along with referral of Senate Bill 1377 to Transportation. The chamber also signed House Bill 1344 after the Senate returned it without amendment. Later, members announced caucus and committee meetings, including Rules, Intergovernmental Affairs and Operations, Insurance, and Appropriations, before recessing and then reconvening for floor votes.
The House adopted several resolutions, including House Resolution 537 designating Rail Safety Week, House Resolution 449 recognizing the 25th anniversary of the September 11 attacks, and House Resolution 568 designating Javei Syndrome Awareness Day. The chamber also considered House Bill 2037 on cryptocurrency corruption, where Amendment A03882 narrowing the bill to public officials and immediate family members was adopted, while two later amendments were tabled or failed. House Bill 2198, repealing the sales and use tax exemption for computer data center equipment, was amended to take effect immediately and to bar KOZ use for data centers, then agreed to. House Bill 2559, concerning a university conveyance and other conveyances, was agreed to after out-of-order amendments were ruled on.
A major portion of the session focused on data center policy. House Bill 2496, creating a 180-day pause on data center proposals to give municipalities time to update zoning and planning, drew extensive support from members emphasizing local control, environmental concerns, and the need for time to assess impacts; it passed final passage 201-1. House Bill 2650, creating the Governor’s Responsible Infrastructure Development certification for data centers, also generated lengthy debate over energy use, water, community benefits, and tax treatment; it passed 134-68. The House also passed House Bill 2162 on temporary licensing for drug manufacturers before FDA approval, House Bill 2388 on rounding cash payments when pennies are unavailable, House Bill 2437 on county and municipal bridge repair funds, House Bill 2555 on equine dealer recordkeeping, and House Bill 2621 directing a Department of Health survey on maternal and infant outcomes.
Other actions included final passage of House Bill 1006 on milk tester and wearer sampler certification periods, House Bill 2014 on opportunities for minors and emergency service organizations, House Bill 2512 prohibiting ride-share pricing based on device condition, House Bill 2644 authorizing itemized capital bridge projects, and Senate Bill 1058 updating the E85 flex-fuel reference. The House also adopted House Bill 2162, House Bill 2388, House Bill 2437, and House Bill 2555 by recorded votes, and several committee reports were agreed to throughout the day. The session ended with additional committee referrals, a motion to recommit several bills to Appropriations, and adjournment until the next morning.
WA
Transcript Highlights:
- Pharmaceutical wholesalers are a critical part of Washington's health care supply chain, safely delivering
- And I would like to point out that this wholesaling for pharmaceutical products is vastly different from
- We don't ask for the same tax rate for the other products that our companies sell, just pharmaceutical
ID
Idaho 2026 Regular Session
Agenda Mar 3rd, 2026
Transcript Highlights:
- So these companies, whether it be pharmaceutical, cosmetics, or food companies, I heard a great senator
- He said that if Idaho passed the bill and a pharmaceutical company sued, Idaho would be preempted immediately
- And I think the second we passed this, and a pharmaceutical company sued us, Idaho would get preempted
Summary:
Senate Commerce approved the February 24, 2026 minutes and heard a gubernatorial reappointment of Jeff Seilich to the Public Employee Retirement System of Idaho board. The committee took no action on the appointment during the meeting, with the chair indicating a vote would likely occur later in the week. PERSI’s director and the nominee described the system as stable and well funded.
The committee then advanced House Bill 543, a technical PERSI bill updating language to comply with federal Secure Act 2.0 requirements by changing post-tax catch-up contribution language to Roth contributions in the PERSI Choice Plan. Representative Ben Furman and PERSI Director Mike Hampton said the change was purely technical. The bill received a due pass recommendation to the Senate floor.
House Bill 563, which revises CPA licensure pathways to address workforce shortages, also received a due pass recommendation. Representative Jeff Ehlers and Idaho Society of CPAs representatives said the bill would create three pathways to licensure, lower education barriers, preserve the exam requirement, and ease reciprocity for out-of-state CPAs. Supporters said the profession is facing retirements and declining exam candidates, while committee members generally supported the effort to reduce barriers.
The committee spent most of the meeting on Senate Bill 1310, the Human Fetal Tissue Transparency Act, which would require product labeling when human fetal tissue or related cell lines were used in testing or production. Supporters argued the bill would provide consumer transparency and informed consent for moral and conscience reasons, while opponents raised concerns about federal preemption, enforcement, costs, and practical implementation, especially for medical products and retailers. After extensive debate, the committee adopted a substitute motion to hold the bill in committee by a 5-4 roll call vote, with Senators Guthrie, Nichols, Burns, Ruchti, and Lenney in favor and Senators Zito, Ward-Engelking, and Foreman opposed, resulting in SB 1310 being held.
WA
Washington 2025-2026 Regular Session
Senate Floor Session Feb 10th, 2026 at 10:00 am
Washington Senate Floor Meeting
Transcript Highlights:
- We are now basically using the Department of Corrections pharmacy, intended for purchasing pharmaceuticals
- for inmates, and we are now a wholesale distributor. ...pharmacy intended for purchasing pharmaceuticals
- President, that would actually establish a state pharmaceutical distribution facility or state pharmacy
Summary:
The Senate opened with roll call, colors, pledge, and a prayer by Sikh youth leader Gertit Singh Cocher, followed by recognition of guests from the Sikh Coalition and Kalsa Germath Center. The chamber approved the journal and then adopted Senate Resolution 8678 honoring the Chimicum High School Marching Band for being selected as Washington’s representative in the 2026 National Independence Day Parade in Washington, D.C.; senators praised the band’s dedication and rural-school achievement, and the band was recognized in the gallery.
The Senate then confirmed two gubernatorial appointments by 49-0 votes: Ryan Moran as Director of the Health Care Authority and Dennis Worsham as Secretary of the Department of Health. Supporters highlighted Moran’s Medicaid and health system background and Worsham’s long public health career, including local health leadership and work on HIV/AIDS and community health. The chamber also advanced and passed Senate Bill 6011, expanding court bailiff authority to conduct threat assessments for the Court of Appeals, and Senate Bill 5831, creating safe harbors related to mortgage modification recording requirements.
Several bills were debated and passed after amendment votes. Senate Bill 6188, concerning Labor and Industries’ asbestos training and certification rules, saw an amendment to align with federal standards rejected and then passed 38-19. Substitute Senate Bill 5917, dealing with access to abortion medications through the Department of Corrections pharmacy, had multiple proposed amendments rejected before passing 32-17 after extensive debate over access, labeling, distribution limits, and emergency status. The Senate also adopted an amendment to Senate Bill 6024 on developmental disability services confidentiality, then passed the bill 48-0-1 excused; passed Substitute Senate Bill 6091 on residential property marketing and fair housing by 49-0; and passed Substitute Senate Bill 5840 adjusting campaign finance expenditure reporting deadlines by 46-3. The body then recessed for caucus and lunch.
FL
Transcript Highlights:
- I was formerly chief marketing officer for a global pharmaceutical company where I was beat nearly to
- I worked for the subsidiary Stratford Pharmaceuticals. I lost my livelihood. I agree.
- I worked for the subsidiary Stratford Pharmaceuticals. I lost my livelihood.
TX
Transcript Highlights:
- So that's really where the money is—that and pharmaceuticals is where the big savings are.
- So the idea that you're just going to have a straight-up price with a hospital or a pharmaceutical company
- I'm with the Pharmaceutical Care Management Association.
Bills:
HB345, HB721, HB2580, SB815, HB3057, HB4603, HB3233, SB495, HB3863, HB3914, HB4570, HB5099, HB5173, SB458
Keywords:
insurance, appraisal process, disputed losses, residential property, policyholder rights, insurer obligations, natural disasters, appraisal expenses, umpire selection, policyholder, insurer, umpire, claims management, health care, cost disclosure, benefit plan, administrators, traumatic brain injury, health benefit plans, insurance coverage
US
US Federal 2025-2026 Regular Session
Hearings to examine combating the opioid epidemic. Feb 26th, 2025 at 02:30 pm
Aging (Special) Committee
Transcript Highlights:
- tackling this problem but how we are expending the resources that our office recovered going after pharmaceutical
- Stein highlights this point in that you're actually only limited to pharmaceutical options a lot of the
- people with pain and making. their pain much more manageable so that we don't have to turn to the pharmaceutical
Keywords:
opioid crisis, overdose, naloxone, drug trafficking, law enforcement, treatment, prevention, older adults, Medicaid expansion
Summary:
The meeting convened to address the dire opioid crisis affecting communities nationwide, with a particular focus on the alarming rise of opioid use disorder among older adults. Key testimonies highlighted the critical need for a comprehensive approach that encompasses prevention, treatment, and strict law enforcement actions against drug traffickers. Sheriff Dennis Lima from Seminole County outlined successful strategies implemented in Florida, including increased access to naloxone and legislative changes to hold drug dealers accountable for overdoses. Various members expressed a united front on tackling this multifaceted issue, advocating for the expansion of Medicaid and better access to treatment as essential steps to curbing the epidemic.
FL
Florida 2025 Regular Session
Commerce and Tourism Feb 4th, 2025
Transcript Highlights:
- statewide achievements likewise in in computer and electronic related products, medical devices, pharmaceuticals
- Second largest producer of pharmaceuticals behind that industry is the state's also huge producer of
- a chemical manufacturing that supports the pharmaceutical industry.
OK
Transcript Highlights:
- their previous stance and saying that these types of procedures, including the medical or the pharmaceutical
- facilitate and promote, refer, or perform these types of procedures, whether they're surgical or pharmaceutical
Keywords:
2030 census, complete count committee, census outreach, decennial census, enumeration, population count, hard-to-count populations, hard-to-enumerate areas, State Data Center, Oklahoma Census, multilingual campaign, public outreach, school-based outreach, community organizations, minority groups, ethnic minorities, language minorities, self-response rate, census awareness, federal census
Summary:
The committee first handled housekeeping, announcing that House Bill 4276 would be laid over until the third week and moving Representative Lawson’s bill to the top of the agenda. HB 3620, creating a 2030 census complete count committee, was presented and passed by due pass. HB 3942, which updates the state’s tax incentive evaluation process by directing reports to LOFT and requiring comparisons to other incentives and strategic economic goals, also passed due pass after brief discussion about whether all tax incentives, including the parental choice tax credit, would be reviewed.
Representative Pfeiffer presented HB 3279, a follow-up public corruption measure that clarifies conflict-of-interest disclosure requirements and sets a $25,000 threshold for certain purchase orders; it passed due pass. After Vice Chair Woolley took over, HB 3378 passed 7-0 to stagger OCAST board terms after all members had expired at once. HB 3383, setting a 14-hour limit on required work in a 24-hour period for state employees with emergency carve-outs, passed 6-1 after questions about law enforcement and emergency-service exceptions. Several transparency and procurement bills from Representative Strom also passed unanimously: HB 3413 requires agencies to report outsourced jobs and consulting outcomes, HB 3414 adds accounting-system reporting for contract type and invoice location for intangible assets, HB 3415 requires subcontractor reporting and post-contract assessments, and HB 3420 requires justification for sole-source purchases and limits pilot or proof-of-concept contracting to 12 months.
The most contentious measure was HB 313 by Representative Kevin West, which restricts state agencies, employees, contractors, and public institutions from using state funds to perform, facilitate, refer, or encourage gender transition procedures. Opponents argued it intrudes into private medical decisions, could affect adults as well as minors, and may worsen health outcomes or create vague enforcement problems; supporters said it protects minors from harmful, life-altering procedures and prevents state dollars from supporting them. After extended debate, the committee passed HB 313 by a 7-2 vote. The meeting then adjourned, with one more committee meeting announced for the following week.
CA
WY
Transcript Highlights:
- So if you start adding in an ECA, even a modest 2%, 3%, 4% ECA and compound that, that's how you get
- So if you start adding in an ECA, even a modest 2%, 3%, 4% ECA and compound that, that's how you get
- So if you start adding in an ECA, even a modest 2%, 3%, 4% ECA and compound that, that's how you get
- Um, when we went before, I felt a little bit like a pharmaceutical rep going to a doctor's office, you
- Um, when we went before, I felt a little bit like a pharmaceutical rep going to a doctor's office, you